4//SEC Filing
Sabatini Brent 4
Accession 0001628280-25-007696
CIK 0001706431other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:37 PM ET
Size
8.6 KB
Accession
0001628280-25-007696
Insider Transaction Report
Form 4
Sabatini Brent
SVP, Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-22+40,000→ 40,000 totalExercise: $9.57Exp: 2035-02-21→ Common Stock (40,000 underlying) - Sale
Common Stock
2025-02-24$9.45/sh−1,562$14,766→ 46,627 total - Award
Common Stock
2025-02-22+20,000→ 48,189 total
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0002037272
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:37 PM ET
- Size
- 8.6 KB